Literature DB >> 22139301

De-regulation of the RBBP6 isoform 3/DWNN in human cancers.

Zukile Mbita1, Mervin Meyer, Amanda Skepu, Margot Hosie, Jasper Rees, Zodwa Dlamini.   

Abstract

Retinoblastoma binding protein 6 (RBBP6) is a nuclear protein, previously implicated in the regulation of cell cycle and apoptosis. The human RBBP6 gene codes for three protein isoforms and isoform 3 consists of the domain with no name domain only whilst the other two isoforms, 1 and 2 comprise of additional zinc, RING, retinoblastoma and p53 binding domains. In this study, the localization of RBBP6 using RBBP6 variant 3 mRNA-specific probe was performed to investigate the expression levels of the gene in different tumours and find a link between RBBP6 and human carcinogenesis. Using FISH, real-time PCR and Western blotting analysis our results show that RBBP6 isoform 3 is down-regulated in human cancers. RBBP6 isoform 3 knock-down resulted in reduced G2/M cell cycle arrest whilst its over-expression resulted in increased G2/M cell cycle arrest using propidium iodide DNA staining. The results further demonstrate that the RBBP6 isoform 3 may be the cell cycle regulator and involved in mitotic apoptosis not the isoform 1 as previously reported for mice. In conclusion, these findings suggest that RBBP6 isoform 3 is a cell cycle regulator and may be de-regulated in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139301     DOI: 10.1007/s11010-011-1150-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Role of ubiquitin- and Ubl-binding proteins in cell signaling.

Authors:  Vladimir Kirkin; Ivan Dikic
Journal:  Curr Opin Cell Biol       Date:  2007-02-15       Impact factor: 8.382

3.  Acid-treated, naked bacteria as immune carriers for protein antigens.

Authors:  D U Bellstedt; P A Human; G F Rowland; K J Van der Merwe
Journal:  J Immunol Methods       Date:  1987-04-16       Impact factor: 2.303

4.  The proliferation potential protein-related (P2P-R) gene with domains encoding heterogeneous nuclear ribonucleoprotein association and Rb1 binding shows repressed expression during terminal differentiation.

Authors:  M M Witte; R E Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

5.  Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.

Authors:  Ying-Nan Yu; George Wai-Cheong Yip; Puay-Hoon Tan; Aye Aye Thike; Ken Matsumoto; Masafumi Tsujimoto; Boon-Huat Bay
Journal:  Int J Oncol       Date:  2010-08       Impact factor: 5.650

6.  Involvement of nuclear receptor coactivator SRC-1 in estrogen-dependent cell growth of MCF-7 cells.

Authors:  H Tai; N Kubota; S Kato
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

7.  Y-box binding protein-1 is a novel molecular target for tumor vessels.

Authors:  Mayu Takahashi; Shohei Shimajiri; Hiroto Izumi; Gen Hirano; Eiji Kashiwagi; Yoshihiro Yasuniwa; Ying Wu; Bin Han; Masaki Akiyama; Shigeru Nishizawa; Yasuyuki Sasaguri; Kimitoshi Kohno
Journal:  Cancer Sci       Date:  2010-02-16       Impact factor: 6.716

8.  Coactivator-mediated estrogen response in human squamous cell carcinoma lines.

Authors:  Tony K S Ku; David L Crowe
Journal:  J Endocrinol       Date:  2007-04       Impact factor: 4.286

9.  Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells.

Authors:  Yuji Basaki; Ken-Ichi Taguchi; Hiroto Izumi; Yuichi Murakami; Takuya Kubo; Fumihito Hosoi; Kosuke Watari; Kenji Nakano; Hidetoshi Kawaguchi; Shinji Ohno; Kimitoshi Kohno; Mayumi Ono; Michihiko Kuwano
Journal:  Eur J Cancer       Date:  2010-01-14       Impact factor: 9.162

10.  DWNN, a novel ubiquitin-like domain, implicates RBBP6 in mRNA processing and ubiquitin-like pathways.

Authors:  David J R Pugh; Eiso Ab; Andrew Faro; Portia T Lutya; Eberhard Hoffmann; D Jasper G Rees
Journal:  BMC Struct Biol       Date:  2006-01-05
View more
  11 in total

1.  Expression analysis and association of RBBP6 with apoptosis in colon cancers.

Authors:  Zodwa Dlamini; Charleen Rupnarain; Sarala Naicker; Rodney Hull; Zukile Mbita
Journal:  J Mol Histol       Date:  2016-02-23       Impact factor: 2.611

Review 2.  Alternative polyadenylation of mRNA precursors.

Authors:  Bin Tian; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2016-09-28       Impact factor: 94.444

3.  Overexpression of RBBP6, alone or combined with mutant TP53, is predictive of poor prognosis in colon cancer.

Authors:  Jian Chen; Huamei Tang; Zehua Wu; Chongzhi Zhou; Tao Jiang; Yingming Xue; Guoyu Huang; Dongwang Yan; Zhihai Peng
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

4.  The Drosophila retinoblastoma binding protein 6 family member has two isoforms and is potentially involved in embryonic patterning.

Authors:  Rodney Hull; Brent Oosthuysen; Umar-Faruq Cajee; Lehlogonolo Mokgohloa; Ekene Nweke; Ricardo Jorge Antunes; Theresa H T Coetzer; Monde Ntwasa
Journal:  Int J Mol Sci       Date:  2015-05-06       Impact factor: 5.923

Review 5.  The end of the message: multiple protein-RNA interactions define the mRNA polyadenylation site.

Authors:  Yongsheng Shi; James L Manley
Journal:  Genes Dev       Date:  2015-05-01       Impact factor: 11.361

6.  RBBP6 isoforms regulate the human polyadenylation machinery and modulate expression of mRNAs with AU-rich 3' UTRs.

Authors:  Dafne Campigli Di Giammartino; Wencheng Li; Koichi Ogami; Jossie J Yashinskie; Mainul Hoque; Bin Tian; James L Manley
Journal:  Genes Dev       Date:  2014-10-15       Impact factor: 11.361

7.  Methyl pyruvate protects a normal lung fibroblast cell line from irinotecan-induced cell death: Potential use as adjunctive to chemotherapy.

Authors:  Bernice Monchusi; Monde Ntwasa
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

8.  Downregulation of RBBP6 variant 1 during arsenic trioxide-mediated cell cycle arrest and curcumin-induced apoptosis in MCF-7 breast cancer cells.

Authors:  Lilian Makgoo; Kagiso Laka; Zukile Mbita
Journal:  Future Sci OA       Date:  2019-07-30

Review 9.  New links between mRNA polyadenylation and diverse nuclear pathways.

Authors:  Dafne Campigli Di Giammartino; James L Manley
Journal:  Mol Cells       Date:  2014-08-01       Impact factor: 5.034

Review 10.  Targeting the Polyadenylation Signal of Pre-mRNA: A New Gene Silencing Approach for Facioscapulohumeral Dystrophy.

Authors:  Anne-Charlotte Marsollier; Romain Joubert; Virginie Mariot; Julie Dumonceaux
Journal:  Int J Mol Sci       Date:  2018-05-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.